Global Phenylbutazone Tablets Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Phenylbutazone Tablets market size was valued at US$ 53.7 million in 2024 and is forecast to a readjusted size of USD 79.2 million by 2031 with a CAGR of 5.8% during review period.

The market trend for Phenylbutazone Tablets is expected to see steady growth over the forecast period. Phenylbutazone is a non-steroidal anti-inflammatory drug (NSAID) used to relieve pain and reduce inflammation in conditions such as arthritis. It works by inhibiting the production of certain chemicals in the body that cause pain and inflammation.One of the key factors driving the market growth is the increasing prevalence of arthritis and other musculoskeletal disorders. Arthritis affects millions of people worldwide and is a leading cause of disability. As the population continues to age and the incidence of chronic diseases rises, the demand for effective pain management options such as Phenylbutazone Tablets is expected to increase.

This report is a detailed and comprehensive analysis for global Phenylbutazone Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Phenylbutazone Tablets market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Phenylbutazone Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Phenylbutazone Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031

Global Phenylbutazone Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Phenylbutazone Tablets

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Phenylbutazone Tablets market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AdvaCare, Dexa Medica, Guangzhou Taiceng Pharma, ShanghaixiandaiHasen(shangqiu)Pharmaceutical, Salutem Pharma, TEYI PHARMACEUTICAL, Mylan Pharmaceuticals Inc., Teva Pharmaceuticals, Qualitest Pharmaceuticals Inc., Watson Laboratories, Inc., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Phenylbutazone Tablets market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

100mg

200mg

Market segment by Application

Osteoarthritis

Rheumatism

Major players covered

AdvaCare

Dexa Medica

Guangzhou Taiceng Pharma

ShanghaixiandaiHasen(shangqiu)Pharmaceutical

Salutem Pharma

TEYI PHARMACEUTICAL

Mylan Pharmaceuticals Inc.

Teva Pharmaceuticals

Qualitest Pharmaceuticals Inc.

Watson Laboratories, Inc.

Perrigo Pharmaceuticals

Actavis US

West-Ward Pharmaceuticals Corp.

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Phenylbutazone Tablets product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Phenylbutazone Tablets, with price, sales quantity, revenue, and global market share of Phenylbutazone Tablets from 2020 to 2025.

Chapter 3, the Phenylbutazone Tablets competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Phenylbutazone Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Phenylbutazone Tablets market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Phenylbutazone Tablets.

Chapter 14 and 15, to describe Phenylbutazone Tablets sales channel, distributors, customers, research findings and conclusion.